5–fluorouracil, adriamycin, cyclophosphamide (FAC) vs. 5–fluorouracil, epirubicin, cyclophosphamide (FEC) in metastatic breast cancer

Massimo Lopez, Paola Papaldo, Luigi Di Lauro, Patrizia Vici, Silvia Carpano, Ettore M S Conti

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of '5–fluorouracil, adriamycin, cyclophosphamide (FAC) vs. 5–fluorouracil, epirubicin, cyclophosphamide (FEC) in metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences